Skip to main content

Advertisement

Log in

The Unique Clinical Characteristics of Melanoma Diagnosed in Children

  • Melanomas
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Studies have demonstrated a higher rate of nodal metastases in melanoma of childhood, but there is controversy about the overall prognosis relative to adults. We describe a large single-institution experience with pediatric melanoma and assess prognostic characteristics.

Methods

Retrospective review identified 126 patients diagnosed with melanoma at <21 years of age and referred for treatment from 1986 to 2011. Atypical lesions were excluded. Clinicopathologic characteristics were correlated with sentinel lymph node (SLN) status and outcomes.

Results

SLN biopsy was positive in 18 of 62 cases (29 %). Increasing Breslow thickness correlated with a positive SLN (p < 0.05). After a median follow-up of 5 years, there were 27 recurrences and 20 deaths. Positive SLN patients had significantly worse recurrence-free survival (RFS, p < 0.05) and significantly worse melanoma-specific survival (MSS, p = 0.05) compared with negative SLN patients. The 5-year RFS and MSS for positive SLN patients were 59.5 and 77.8 %, compared with 93.7 and 96.8 % for negative SLN patients. Recurrences and melanoma-related deaths were often seen beyond 5 years. No deaths have occurred in patients <12 years, but 9.1 % of patients 12–17 years and 17.2 % of patients 18–20 years died from melanoma (p = 0.291).

Conclusions

Children with melanoma have higher rates of SLN metastases (29 %) than adults with comparable melanomas. Despite the higher incidence of nodal metastases, survival is equal to or better than what is reported for adults. However, long-term follow-up is necessary in this population since recurrences and deaths are often seen beyond 5 years.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Siegel R, Naishadham D, Jemal A. Cancer statistics 2012. CA Cancer J Clin. 2012;62:10–29.

    Article  PubMed  Google Scholar 

  2. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER Cancer Statistics Review, 1975–2008. National Cancer Institute, Bethesda, http://seer.cancer.gov/csr/1975_2008/, based on November 2010 SEER data submission, posted to the SEER web site, 2011.

  3. de Vries E, Steliarova-Foucher E, Spatz A, Ardanaz E, Eggermont AM, Coebergh JW. Skin cancer incidence and survival in European children and adolescents (1978–1997). Report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42:2170–82.

    Article  PubMed  Google Scholar 

  4. Ceballos PI, Ruiz-Maldonado R, Mihm MC, Jr. Melanoma in children. N Engl J Med. 1995;332:656–62.

    Article  PubMed  CAS  Google Scholar 

  5. Linabery AM, Ross JA. Trends in childhood cancer incidence in the U.S. (1992–2004). Cancer. 2008;112:416–32.

    Article  PubMed  Google Scholar 

  6. Strouse JJ, Fears TR, Tucker MA, Wayne AS. Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. J Clin Oncol. 2005;23:4735–41.

    Article  PubMed  Google Scholar 

  7. Pappo AS. Melanoma in children and adolescents. Eur J Cancer. 2003;39:2651–61.

    Article  PubMed  CAS  Google Scholar 

  8. Jen M, Murphy M, Grant-Kels JM. Childhood melanoma. Clin Dermatol. 2009;27:529–36.

    Article  PubMed  Google Scholar 

  9. Hamre MR, Chuba P, Bakhshi S, Thomas R, Severson RK. Cutaneous melanoma in childhood and adolescence. Pediatr Hematol Oncol. 2002;19:309–17.

    Article  PubMed  Google Scholar 

  10. Downard CD, Rapkin LB, Gow KW. Melanoma in children and adolescents. Surg Oncol. 2007;16:215–20.

    Article  PubMed  Google Scholar 

  11. Mills O, Messina JL. Pediatric melanoma: a review. Cancer Control. 2009;16:225–33.

    PubMed  Google Scholar 

  12. Paradela S, Fonseca E, Prieto VG. Melanoma in children. Arch Pathol Lab Med. 2011;135:307–16.

    PubMed  Google Scholar 

  13. Livestro DP, Kaine EM, Michaelson JS, Mihm MC, Haluska FG, Muzikansky A, et al. Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis. Cancer. 2007;110:614–24.

    Article  PubMed  Google Scholar 

  14. Moore-Olufemi S, Herzog C, Warneke C, Gershenwald JE, Mansfield P, Ross M, et al. Outcomes in pediatric melanoma: comparing prepubertal to adolescent pediatric patients. Ann Surg. 2011;253:1211–5.

    Article  PubMed  Google Scholar 

  15. Aldrink JH, Selim MA, Diesen DL, Johnson J, Pruitt SK, Tyler DS, et al. Pediatric melanoma: a single-institution experience of 150 patients. J Pediatr Surg. 2009; 44:1514–21.

    Article  PubMed  Google Scholar 

  16. Butter A, Hui T, Chapdelaine J, Beaunoyer M, Flageole H, Bouchard S. Melanoma in children and the use of sentinel lymph node biopsy. J Pediatr Surg. 2005;40:797–800.

    Article  PubMed  Google Scholar 

  17. Roaten JB, Partrick DA, Pearlman N, Gonzalez RJ, Gonzalez R, McCarter MD. Sentinel lymph node biopsy for melanoma and other melanocytic tumors in adolescents. J Pediatr Surg. 2005;40:232–5.

    Article  PubMed  Google Scholar 

  18. Roaten JB, Partrick DA, Bensard D, Pearlman N, Gonzalez R, Fitzpatrick J, et al. Survival in sentinel lymph node-positive pediatric melanoma. J Pediatr Surg. 2005;40:988–92; discussion 92.

    Article  PubMed  Google Scholar 

  19. Howman-Giles R, Shaw HM, Scolyer RA, Murali R, Wilmott J, McCarthy SW, et al. Sentinel lymph node biopsy in pediatric and adolescent cutaneous melanoma patients. Ann Surg Oncol. 2010;17:138–43.

    Article  PubMed  Google Scholar 

  20. Chao C, Martin RC, 2nd, Ross MI, Reintgen DS, Edwards MJ, Noyes RD, et al. Correlation between prognostic factors and increasing age in melanoma. Ann Surg Oncol. 2004;11:259–64.

    Article  PubMed  Google Scholar 

  21. Kirkwood JM, Jukic DM, Averbook BJ, Sender LS. Melanoma in pediatric, adolescent, and young adult patients. Semin Oncol. 2009;36:419–31.

    Article  PubMed  CAS  Google Scholar 

  22. Paradela S, Fonseca E, Pita-Fernandez S, Kantrow SM, Diwan AH, Herzog C, et al. Prognostic factors for melanoma in children and adolescents: a clinicopathologic, single-center study of 137 patients. Cancer. 2010;116:4334–44.

    Article  PubMed  Google Scholar 

  23. Lewis KG. Trends in pediatric melanoma mortality in the United States, 1968 through 2004. Dermatol Surg. 2008;34:152–9.

    Article  PubMed  CAS  Google Scholar 

  24. Ferrari A, Bono A, Baldi M, Collini P, Casanova M, Pennacchioli E, et al. Does melanoma behave differently in younger children than in adults? A retrospective study of 33 cases of childhood melanoma from a single institution. Pediatrics. 2005;115:649–54.

    Article  PubMed  Google Scholar 

  25. Lange JR, Palis BE, Chang DC, Soong SJ, Balch CM. Melanoma in children and teenagers: an analysis of patients from the National Cancer Data Base. J Clin Oncol. 2007;25:1363–8.

    Article  PubMed  Google Scholar 

  26. Daryanani D, Plukker JT, Nap RE, Kuiper H, Hoekstra HJ. Adolescent melanoma: risk factors and long term survival. Eur J Surg Oncol. 2006;32:218–23.

    Article  PubMed  CAS  Google Scholar 

  27. Euling SY, Herman-Giddens ME, Lee PA, Selevan SG, Juul A, Sørensen TI, et al. Examination of US puberty-timing data from 1940 to 1994 for secular trends: panel findings. Pediatrics. 2008;121 Suppl 3:S172–91.

    Article  PubMed  Google Scholar 

  28. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199–206.

    Article  PubMed  Google Scholar 

  29. Phan GQ, Messina JL, Sondak VK, Zager JS. Sentinel lymph node biopsy for melanoma: indications and rationale. Cancer Control. 2009;16:234–9.

    PubMed  Google Scholar 

Download references

Disclosures

VKS: Consultant/Advisory Board: Merck, Navidea (Neoprobe); JSZ: Consultant/Scientific Advisory Board for Delcath Systems, Inc. and a Consultant to IGEA; JLM: Consultant: Glaxo Smith Kline, Consultant: Durect Corporation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vernon K. Sondak MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Han, D., Zager, J.S., Han, G. et al. The Unique Clinical Characteristics of Melanoma Diagnosed in Children. Ann Surg Oncol 19, 3888–3895 (2012). https://doi.org/10.1245/s10434-012-2554-5

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-012-2554-5

Keywords

Navigation